Revealing the dynamics of fungal disease with proteomics
Mazmanian Sa,
No information about this author
Manuela Silva,
No information about this author
Brianna Ball
No information about this author
et al.
Molecular Omics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
The
occurrence
and
distribution
of
new
re-emerging
fungal
pathogens,
along
with
rates
antifungal
resistance,
are
rising
across
the
globe,
correspondingly,
so
our
awareness
call
for
action
to
address
this
public
health
concern.
To
effectively
detect,
monitor,
treat
infections,
biological
insights
into
mechanisms
that
regulate
pathogenesis,
influence
survival,
promote
resistance
urgently
needed.
Mass
spectrometry-based
proteomics
is
a
high-resolution
technique
enables
identification
quantification
proteins
diverse
systems
better
understand
biology
driving
phenotypes.
In
review,
we
highlight
dynamic
innovative
applications
characterize
three
critical
pathogens
(i.e.,
Candida
spp.,
Cryptococcus
Aspergillus
spp.)
causing
disease
in
humans.
We
present
strategies
investigate
host-pathogen
interface,
virulence
factor
production,
protein-level
drivers
resistance.
Through
these
studies,
opportunities
biomarker
development,
drug
target
discovery,
immune
system
remodeling
discussed,
supporting
use
combat
plethora
diseases
threatening
global
health.
Language: Английский
Aspergillus fumigatus secondary metabolite pyripyropene is important for the dual biofilm formation with Pseudomonas aeruginosa
mBio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
ABSTRACT
The
human
pathogenic
fungus
Aspergillus
fumigatus
establishes
dual
biofilm
interactions
in
the
lungs
with
bacterium
Pseudomonas
aeruginosa
.
Screening
of
21
A
null
mutants
revealed
seven
(two
G
protein-coupled
receptors,
three
mitogen-activated
protein
kinase
a
Gα
protein,
and
one
histidine
receptor)
reduced
formation,
specifically
presence
P.
Transcriptional
profiling
metabolomics
analysis
secondary
metabolites
produced
by
these
mutants,
Δ
gpaB
(
encodes
protein),
showed
GpaB
controls
production
several
important
for
interaction,
including
pyripyropene
A,
potent
inhibitor
mammalian
acyl-CoA
cholesterol
acyltransferase.
Deletion
pyr2
,
encoding
non-reducing
polyketide
synthase
essential
biosynthesis,
A.
pyr2-P.
growth,
altered
macrophage
responses,
attenuated
mouse
virulence
chemotherapeutic
murine
model.
We
identified
as
novel
player
ecology
this
fungal
pathogen.
IMPORTANCE
are
two
pathogens.
Both
organisms
establish
patients
affected
chronic
lung
pulmonary
infections,
such
cystic
fibrosis
(CF)
obstructive
disease.
Colonization
is
associated
an
increased
risk
colonization
CF
patients,
disease
prognosis
poor
when
both
pathogens
present.
Here,
we
genetic
determinants
establishment
vitro
fumigatus-P.
interactions.
Among
them,
interaction
controlling
metabolite
pyripyropene.
demonstrate
that
lack
decreases
between
species
well
model
aspergillosis.
These
results
reveal
complete
role
Language: Английский
Unveiling the fungal frontier: mycological insights into inflammatory bowel disease
S. Chen,
No information about this author
MinKyung Yi,
No information about this author
Xiaowei Yi
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 26, 2025
Inflammatory
bowel
disease
(IBD)
is
a
chronic
recurrent
gastrointestinal
that
seriously
affects
the
quality
of
life
patients
around
world.
It
characterized
by
abdominal
pain,
diarrhea,
and
mucous
bloody
stools.
There
an
urgent
need
for
more
accurate
diagnosis
effective
treatment
IBD.
Accumulated
evidence
suggests
gut
microbiota
plays
important
role
in
occurrence
development
inflammation.
However,
most
studies
on
IBD
have
focused
bacteria,
while
fungal
microorganisms
been
neglected.
Fungal
dysbiosis
can
activate
host
protective
immune
pathway
related
to
integrity
epithelial
barrier
release
variety
pro-inflammatory
cytokines
trigger
inflammatory
response.
Dectin-1,
CARD9,
IL-17
signaling
pathways
may
be
drivers
dysbacteriosis
In
addition,
fungal-bacterial
interactions
fungal-derived
metabolites
also
play
role.
Based
this
information,
we
explored
new
strategies
targeting
intestinal
group
its
metabolites,
such
as
probiotics,
antifungal
drugs,
diet
therapy,
fecal
transplantation
(FMT).
This
review
aims
summarize
pathogenesis
IBD,
provide
insights
directions
further
research
emerging
field.
Language: Английский
Theoretical conformational analysis of cross-linking bonds in fungal hydrophobin from Aspergillus fumigatus
Fabiola E. Medina,
No information about this author
Juana Coloma,
No information about this author
Claudia Oviedo
No information about this author
et al.
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 10
Published: April 23, 2025
Aspergillus
fumigatus
is
a
common
saprophytic
filamentous
fungus
that
plays
crucial
role
in
nutrient
cycling
but
can
become
an
opportunistic
pathogen,
posing
significant
threat
to
immunocompromised
individuals
by
causing
invasive
aspergillosis.
A
key
feature
of
A.
the
presence
hydrophobins-small
amphipathic
proteins
form
protective
rodlet
layer
on
conidial
surfaces,
facilitating
biofilm
formation
and
immune
evasion.
This
structure,
stabilized
cross-linking
disulfide
bonds,
provides
resistance
desiccation,
oxidative
stress,
defenses,
making
these
cross-links
compelling
target
for
study.
In
this
work,
we
employ
all-atom
simulations,
incorporating
quantum
mechanics/molecular
mechanics
(QM/MM)
calculations,
evaluate
energy
conformational
effects
bonds
(CL1,
CL2,
CL3,
CL4)
assembly.
By
integrating
QM/MM
approaches,
achieve
detailed
representation
electronic
structural
properties
within
complex
layer,
gaining
deeper
insights
into
their
essential
maintaining
stability
integrity
RodA
hydrophobin
protein
from
surface.
We
identify
group
ten
residues
influence
directly
cross-linking,
with
Gln23
Lys17
emerging
as
candidates
experimental
mutation
control
Our
findings
shed
light
molecular
mechanisms
underlying
highlight
potential
targets
disrupting
offering
promising
avenues
antifungal
strategies.
Language: Английский